About MVision AI
MVision AI is a company based in Helsinki (Finland) founded in 2017 by Saad Ullah Akram, Mahmudul Hasan, and Heikki Arponen. It operates as a AI-as-a-Service, Subscription Services, and HealthTech. MVision AI has raised $6.56 million across 2 funding rounds from investors including Voima Ventures, J12 and Icebreaker.vc. MVision AI offers products and services including GBS™, Contour+, Guide, Verify, and Dose+. MVision AI operates in a competitive market with competitors including Manteia technology, Vision RT, Applied Computational Technologies, Virtual Phantoms and Radiopharmaceutical Imaging and Dosimetry, among others.
- Headquarter Helsinki, Finland
- Founders Saad Ullah Akram, Mahmudul Hasan, Heikki Arponen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mvision Ai Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.56 M (USD)
in 2 rounds
-
Latest Funding Round
$5.83 M (USD), Series A
Mar 23, 2023
-
Investors
Voima Ventures
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MVision AI
MVision AI offers a comprehensive portfolio of products and services, including GBS™, Contour+, Guide, Verify, and Dose+.
Guideline-based segmentation suite for precise radiotherapy planning.
AI-powered auto-contouring for fast, consistent radiotherapy planning.
Training environment for guideline expertise in contouring practice.
Contour comparison tool for analyzing accuracy across sources.
AI-guided dose prediction for optimized radiotherapy treatment plans.
People of MVision AI
Unlock access to complete
Funding Insights of MVision AI
MVision AI has successfully raised a total of $6.56M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.83 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MVision AI
MVision AI has secured backing from 6 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Voima Ventures, J12 and Icebreaker.vc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding is provided for deep tech ventures in Nordics.
|
Locked | Locked | Locked | |
|
Seed and early-stage tech investments are targeted in Finland.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for MVision AI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MVision AI
Investment portfolio details for MVision AI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MVision AI
Detailed financials for MVision AI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mvision Ai Comparisons
Peer comparison for MVision AI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MVision AI
MVision AI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Manteia technology, Vision RT, Applied Computational Technologies, Virtual Phantoms and Radiopharmaceutical Imaging and Dosimetry, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Adaptive radiotherapy system for disease diagnosis is provided.
|
|
| Locked | Locked | Locked |
Optical guidance technologies are developed to enhance radiological imaging quality.
|
|
| Locked | Locked | Locked |
Radiation dose calculation software for cancer treatment is developed.
|
|
| Locked | Locked | Locked |
Radiation dose calculations are enabled via virtual phantom software.
|
|
| Locked | Locked | Locked |
Quantitative imaging and dosimetry software is developed for radiopharmaceutical therapy.
|
|
| Locked | Locked | Locked |
Provides 3D printed replicas for radiotherapy treatment verification.
|
Detailed competitors of MVision AI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mvision Ai
Complete news archive for MVision AI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MVision AI
MVision AI was founded in 2017 and raised its 1st funding round 1 year after it was founded.
MVision AI is headquartered in Helsinki, Finland.
Mahmudul Hasan is the current CEO of MVision AI. They have also founded this company.
MVision AI is a funded company, having raised a total of $6.56M across 2 funding rounds to date.
AI-driven software solutions for radiotherapy planning and treatment optimization are provided by MVision AI. Focus is placed on guideline-based segmentation and dose prediction through products like GBS, Contour, Guide, Verify, and Dose. The healthcare sector, specifically radiation oncology, is served by integrating these tools with existing treatment planning systems. Efficiency in clinical workflows is enhanced, reducing contouring time significantly. Worldwide, leading clinics rely on these solutions to treat cancer patients, aiming for same-day treatment delivery. Innovation is driven by collaboration with radiation oncologists, therapists, and medical physicists to improve patient outcomes.
MVision AI's top competitors include Vision RT, Manteia technology and Virtual Phantoms.
MVision AI offers GBS™, Contour+, Guide, Verify, and Dose+.
MVision AI has 6 investors. Key investors include Voima Ventures, J12, Icebreaker.vc, Otto Söderlund, and Asko Schrey.